General Announcement::Formation of the Audit and Risk Committee and Reconstitution of the Board Committees

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
IX BIOPHARMA LTD. W260718 - SGXN57296778 - HQXW
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
17-Oct-2024 19:06:08
Status
New
Announcement Sub Title
Formation of the Audit and Risk Committee and Reconstitution of the Board Committees
Announcement Reference
SG241017OTHREYJ2
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)

Please refer to the attached.

Attachments

Gen Ann - formation arc reconstn - final.pdf
Total size =77K